Saregama India posts 13% EBITDA growth in FY26 on cost control
Saregama India Limited achieved a 13% rise in Adjusted EBITDA to ₹4,047 Mn in FY26, offsetting a 16% revenue drop with a 29% cut in expenses. PAT increased 1% to ₹2,062 Mn, with margins expanding to 41%. The company invested heavily in content and acquisitions, leading to a decrease in cash reserves.

*this image is generated using AI for illustrative purposes only.
Saregama India Limited reported a 13% year-on-year increase in Adjusted EBITDA to ₹4,047 Mn for FY26, driven by significant cost containment despite a 16% decline in revenue. The company’s Profit After Tax (PAT) rose 1% to ₹2,062 Mn, while Adjusted EBITDA margins expanded from 30% in FY25 to 41% in FY26. This performance underscores the firm's ability to protect profitability through expense management even as top-line growth contracted.
The financial results were disclosed in a corporate presentation submitted to the National Stock Exchange of India Limited and BSE Limited on July 24, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing details the company’s operational and financial performance for the fiscal year ended March 31, 2026.
Financial Performance Highlights
Revenue from operations decreased by 16% to ₹9,846 Mn in FY26, compared to ₹11,713 Mn in FY25 and ₹8,030 Mn in FY24. However, total expenses dropped sharply by 29% to ₹5,799 Mn from ₹8,147 Mn in the previous year. This divergence allowed the Adjusted EBITDA margin to widen significantly. Operational Profit Before Tax (PBT) increased by 8% to ₹2,926 Mn. An exceptional item loss of ₹85 Mn reduced the final PBT to ₹2,841 Mn, a 3% increase over FY25.
| Metric (INR Mn) | FY26 | FY25 | YoY Change |
|---|---|---|---|
| Revenue from Operations | 9,846 | 11,713 | (16%) |
| Total Expenses | 5,799 | 8,147 | (29%) |
| Adjusted EBITDA | 4,047 | 3,566 | 13% |
| Adjusted EBITDA Margin | 41% | 30% | - |
| PAT | 2,062 | 2,043 | 1% |
| Diluted EPS | 10.73 | 10.61 | - |
Balance Sheet and Cash Flow
The company’s net worth grew to ₹16,927 Mn in FY26 from ₹15,834 Mn in FY25. Borrowings increased, with non-current borrowings rising to ₹95 Mn and current borrowings reaching ₹609 Mn, compared to nil in FY25. Cash and cash equivalents declined to ₹282 Mn at the end of FY26 from ₹694 Mn in FY25, reflecting a net decrease of ₹447 Mn. Net cash generated from operating activities stood at ₹1,553 Mn, while investing activities consumed ₹1,686 Mn, largely due to content spending of ₹2,653 Mn and acquisition consideration of ₹3,361 Mn.
| Balance Sheet Item (INR Mn) | FY26 | FY25 |
|---|---|---|
| Net Worth | 16,927 | 15,834 |
| Total Assets | 23,220 | 20,952 |
| Cash & Equivalents | 282 | 694 |
| Total Borrowings | 704 | - |
What the Numbers Show
The most critical insight from Saregama India’s FY26 results is the decoupling of revenue decline from profitability growth. While revenue fell by 16%, the 29% reduction in total expenses more than compensated, leading to a 13% rise in Adjusted EBITDA. This suggests a strategic shift towards higher-margin activities or rigorous cost optimization. Furthermore, the expansion of EBITDA margin from 30% to 41% indicates improved operational efficiency. However, the significant cash outflow for content creation (₹2,653 Mn) and acquisitions (₹3,361 Mn) highlights continued heavy investment in intellectual property, which may pressure near-term liquidity despite strong operating cash flows.
Historical Stock Returns for Saregama India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.59% | +1.42% | +4.88% | +48.76% | +0.37% | +51.84% |
Will the aggressive cost-cutting measures that drove the EBITDA margin expansion to 41% be sustainable without further eroding the already declining revenue base?
How will the significant increase in borrowings and depletion of cash reserves impact Saregama's liquidity position and credit rating in FY27?
What specific strategic synergies or revenue streams are expected from the ₹3,361 Mn in acquisitions to justify the heavy capital outlay amidst falling top-line growth?


































